Know Cancer

or
forgot password

Dynamic FDG-PET in Aggressive Lymphoma and Pancreas Cancer


Phase 0
18 Years
N/A
Not Enrolling
Both
Pancreatic Cancer

Thank you

Trial Information

Dynamic FDG-PET in Aggressive Lymphoma and Pancreas Cancer


Inclusion Criteria:



- age>18

- newly diagnosed untreated aggressive NHL

- newly diagnosed untreated cancer of pancreas

Exclusion Criteria:

- none

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Prospective

Outcome Measure:

The impact of the imaging modality on patient management

Outcome Time Frame:

5 years

Safety Issue:

No

Principal Investigator

Ora Israel, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Rambam Health Care Campus

Authority:

Israel: Israeli Health Ministry Pharmaceutical Administration

Study ID:

PETDCTIL

NCT ID:

NCT00294840

Start Date:

August 2006

Completion Date:

April 2010

Related Keywords:

  • Pancreatic Cancer
  • Pancreatic Neoplasms

Name

Location